MARKSANS PHARMA: US FDA INSPECTION SUCCESSFUL

Facility: Goa Unit 📅 Inspection Period: Nov 3–7, 2025 🇺🇸 Authority: US FDA 📋 Outcome: Zero Form 483 Observations • Inspection concluded successfully with no observations raised. • MD Mark Saldanha said the result reaffirms the company’s strong commitment to product quality and regulatory compliance.